RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Article

Assessment of Affordances in the Home Environment and Neurodevelopment of Children With Congenital Zika Syndrome

January 01, 2025
Article

Community-Sourced Reporting of Mortalities in Angelman Syndrome (1979-2022)

December 16, 2024
Article

A systematic framework for selecting gene-condition pairs for inclusion in newborn sequencing panels: Early check implementation

December 01, 2024
Article

The breastfeeding experiences of mother-infant dyads and the effects of an fmr1 mutation

November 25, 2024
Article

Early Intervention services in the era of genomic medicine: setting a research agenda

October 22, 2024
Article

Adaptive skills of individuals with Angelman syndrome assessed using the vineland adaptive behavior scales, 2nd edition

October 01, 2024
Article

Experiences of Spanish-speaking families with a remote neurodevelopmental assessment

September 18, 2024
Article

Feeding practices and weight status of children with congenital Zika syndrome: A longitudinal study in Brazil

September 01, 2024
Article

Developmental milestones and daily living skills in individuals with Angelman syndrome

June 15, 2024
Article

Specificity of early childhood hyperphagia profiles in neurogenetic conditions

May 01, 2024
Article

Linking Angelman and dup15q data for expanded research (LADDER) database: A model for advancing research, clinical guidance, and therapeutic development for rare conditions

May 01, 2024
Article

Misunderstood terms and concepts identified through user testing of educational materials for fragile X premutation: "Not weak or fragile?"

April 01, 2024
Article

The multiple odysseys in research and clinical care for neurogenetic conditions

March 01, 2024